TPWA
TAK icon

TRUE Private Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

TRUE Private Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45
Closed – – 763
2020
Q3 		$0 Sell
45
-216
-83% -$3.93K ﹤0.01% 737
2020
Q2 		$4K Sell
261
-89
-25% -$1.6K ﹤0.01% 586
2020
Q1 		$5K Sell
350
-3,379
-91% -$61.2K ﹤0.01% 527
2019
Q4 		$73K Buy
+3,729
New +$71.3K 0.01% 324
2019
Q3 		– Sell
-3,573
Closed -$63K – 651
2019
Q2 		$63K Buy
+3,573
New +$65K 0.01% 314

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

TRUE Private Wealth Advisors's TAK Position: Q4 2020 in Review

TRUE Private Wealth Advisors sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 45 shares.

TRUE Private Wealth Advisors first reported a position in TAK in Q2 2019 and held it in 5 quarters. The position peaked at $73K in Q4 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • TRUE Private Wealth Advisors reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 45 Takeda Pharmaceutical shares in Q4 2020.
  • TRUE Private Wealth Advisors first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 5 quarters.
  • TRUE Private Wealth Advisors's Takeda Pharmaceutical position peaked at $73K in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2020, filed 11 Jan 2021.